Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
MEDIUM RISK
Score updated Oct 13, 2026

AGL — agilon health, inc. Dilution Risk Tracker

Track AGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGL — Get alerts when the score changes →

As of October 13, 2026, agilon health, inc. (AGL) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. agilon health, inc. has a market capitalization of $1.44B, 16.79M shares outstanding, 13 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AGL.
🔔 Track AGL — Get forecast alerts →

Market Data

Market Cap$1.44B
Shares Outstanding16.79M
Float9.83M
Cash$529.68M
Debt$30.29M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore29/100DilutionWatch score record
Shares Outstanding16.79MVerified float table or market cache
Public Float9.83MVerified float table or market cache
Market Cap$1.44BMarket data cache
Cash Runway54.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 56.2% shares (2026Q1 vs prior)
13 institutional holders · 165.77M shares
#1 MORGAN STANLEY 113.26M shares
#2 Rubicon Founders LLC 25.32M shares
#3 GOLDMAN SACHS GROUP INC 20.06M shares
+ 10 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.01M
Days to Cover3.8
% of Float10.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-02-27
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AGL Dilution Snapshot

agilon health, inc. (AGL) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AGL's DilutionScore is currently 29/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 28/100 (Medium risk).

Period Score Risk Level Duration
Sep 16 – Oct 13, 202629/100MEDIUM28 days
Jul 16 – Sep 15, 202628/100MEDIUM61 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

AGL shares outstanding have decreased 96.0% from 414.87M (Mar 2026) to 16.68M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 22, 202616.68M9.83M▲ 1046.42%
May 19, 202616.68M857.2K▼ 92.05%
May 18, 202616.68M10.78M▼ 0.18%
May 12, 202616.68M10.80M▼ 33.84%
May 11, 202616.68M16.33M▲ 51.15%
May 10, 202616.68M10.80M▲ 0.08%
May 09, 202616.68M10.80M▲ 0.54%
May 02, 202616.66M10.74M▲ 0.22%
Apr 27, 202616.66M10.71M▼ 0.02%
Apr 15, 202616.61M10.72M▼ 0.43%
Mar 13, 2026414.87M269.10M▼ 0.57%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track AGL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AGL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AGL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AGL
AGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.